Nemolizumab

U.S. Department of Health & Human Services Divider Arrow

National Institutes of Health Divider Arrow

NCATS

Approval Year

Name

Type

Language

Nemolizumab

Official Name

English

NEMOLIZUMAB [USAN]

Common Name

English

immunoglobulin G2-kappa, anti-[Homo sapiens IL31RA (interleukin 31 receptor subunit alpha)], humanized monoclonal antibody gamma2 heavy chain (1-445) [humanized VH (Homo sapiens IGHV1-2*02 (83.70%) -(IGHD)-IGHJ5*01) [8.8.14] (1-121) -Homo sapiens IGHG2*0

Common Name

English

CIM-331

Code

English

NEMOLIZUMAB [JAN]

Common Name

English

Immunoglobulin G2, anti-(interleukin 31 receptor A) (human-Mus musculus monoclonal CIM331 γ-chain), disulfide with human-Mus musculus monoclonal CIM331 κ-chain, dimer

Common Name

English

nemolizumab [INN]

Common Name

English

CIM331

Code

English

Nemolizumab [WHO-DD]

Common Name

English

Code System Code Type Description

CAS

1476039-58-3

Created by admin on Sat Dec 16 09:23:55 GMT 2023 , Edited by admin on Sat Dec 16 09:23:55 GMT 2023

PRIMARY

FDA UNII

GN465U8B72

Created by admin on Sat Dec 16 09:23:55 GMT 2023 , Edited by admin on Sat Dec 16 09:23:55 GMT 2023

PRIMARY

WIKIPEDIA

Nemolizumab

Created by admin on Sat Dec 16 09:23:55 GMT 2023 , Edited by admin on Sat Dec 16 09:23:55 GMT 2023

PRIMARY

DRUG BANK

DB15252

Created by admin on Sat Dec 16 09:23:55 GMT 2023 , Edited by admin on Sat Dec 16 09:23:55 GMT 2023

PRIMARY

INN

10064

Created by admin on Sat Dec 16 09:23:55 GMT 2023 , Edited by admin on Sat Dec 16 09:23:55 GMT 2023

PRIMARY

USAN

LM-25

Created by admin on Sat Dec 16 09:23:55 GMT 2023 , Edited by admin on Sat Dec 16 09:23:55 GMT 2023

PRIMARY

NCI_THESAURUS

C170211

Created by admin on Sat Dec 16 09:23:55 GMT 2023 , Edited by admin on Sat Dec 16 09:23:55 GMT 2023

PRIMARY

ACTIVE MOIETY


					GN465U8B72